Literature DB >> 31300199

Postnatal Runx2 deletion leads to low bone mass and adipocyte accumulation in mice bone tissues.

Ikue Tosa1, Daisuke Yamada2, Misa Yasumatsu2, Eiichi Hinoi3, Mitsuaki Ono4, Toshitaka Oohashi4, Takuo Kuboki5, Takeshi Takarada6.   

Abstract

Global gene deletion studies have established that Runt-related transcription factor-2 (Runx2) is essential during skeletogenesis for osteoblastic differentiation in both intramembranous and endochondral ossification processes. However, the postnatal significance of Runx2 in vivo is poorly understood because a global Runx2 deletion causes perinatal lethality. In this study, we generated tamoxifen-induced Runx2 global deficient mice by crossing Runx2flox mice with ROSA26-CreERT2 mice (Rosa26-CreERT2; Runx2flox/flox). Four-week-old mice were intraperitoneally treated with tamoxifen for five consecutive days, sacrificed, and analyzed six weeks after tamoxifen administration. Deletion of Runx2 led to low bone mass, which is associated with decreased bone formation and bone resorption as well as excessive bone marrow adiposity. Collectively, postnatal Runx2 absolutely plays an important role in maintaining the homeostasis of bone tissues not only in bone mass, but also in the bone marrow environment.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Bone marrow adiposity; Conditional knockout; Osteoporosis; Runx2

Mesh:

Substances:

Year:  2019        PMID: 31300199     DOI: 10.1016/j.bbrc.2019.07.014

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Vestigial-Like 3 Plays an Important Role in Osteoblast Differentiation by Regulating the Expression of Osteogenic Transcription Factors and BMP Signaling.

Authors:  Haoze Yuan; Mika Ikegame; Yoko Fukuhara; Fumiko Takemoto; Yaqiong Yu; Jumpei Teramachi; Yao Weng; Jiajie Guo; Daisuke Yamada; Takeshi Takarada; Ying Li; Hirohiko Okamura; Bin Zhang
Journal:  Calcif Tissue Int       Date:  2022-06-24       Impact factor: 4.000

2.  Imatinib has minimal effects on inflammatory and osteopenic phenotypes in a murine cherubism model.

Authors:  Tomoyuki Mukai; Takahiko Akagi; Sumie Hiramatsu Asano; Ikue Tosa; Mitsuaki Ono; Mizuho Kittaka; Yasuyoshi Ueki; Ayano Yahagi; Masanori Iseki; Toshitaka Oohashi; Katsuhiko Ishihara; Yoshitaka Morita
Journal:  Oral Dis       Date:  2021-11-07       Impact factor: 4.068

3.  Targeted Ptpn11 deletion in mice reveals the essential role of SHP2 in osteoblast differentiation and skeletal homeostasis.

Authors:  Lijun Wang; Huiliang Yang; Jiahui Huang; Shaopeng Pei; Liyun Wang; Jian Q Feng; Dian Jing; Hu Zhao; Henry M Kronenberg; Douglas C Moore; Wentian Yang
Journal:  Bone Res       Date:  2021-01-27       Impact factor: 13.567

4.  Low-Dose Tamoxifen Induces Significant Bone Formation in Mice.

Authors:  Zhihui Xie; Cody McGrath; Jeyantt Sankaran; Maya Styner; Sarah Little-Letsinger; Amel Dudakovic; Andre J van Wijnen; Janet Rubin; Buer Sen
Journal:  JBMR Plus       Date:  2021-01-20

5.  Bortezomib Rescues Ovariectomy-Induced Bone Loss via SMURF-Mediated Ubiquitination Pathway.

Authors:  Yuepeng Fang; Yang Liu; Zhijian Zhao; Yingjie Lu; Xu Shen; Tianfeng Zhu; Mingzhuang Hou; Fan He; Huilin Yang; Yijian Zhang; Qin Shi; Xuesong Zhu
Journal:  Oxid Med Cell Longev       Date:  2021-12-31       Impact factor: 6.543

Review 6.  Biomolecules Orchestrating Cardiovascular Calcification.

Authors:  Yin Tintut; Henry M Honda; Linda L Demer
Journal:  Biomolecules       Date:  2021-10-07

7.  Effects of runt-related transcription factor 2 (RUNX2) on the autophagy of rapamycin-treated osteoblasts.

Authors:  Cheng Ren; Yibo Xu; Hongliang Liu; Zhimeng Wang; Teng Ma; Zhong Li; Liang Sun; Qiang Huang; Kun Zhang; Chengcheng Zhang; Yu Cui; Qian Wang; Yao Lu
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

Review 8.  Effects and Mechanisms of Five Psoralea Prenylflavonoids on Aging-Related Diseases.

Authors:  Yi-Ting Zhou; Lin Zhu; Yunyun Yuan; Shuang Ling; Jin-Wen Xu
Journal:  Oxid Med Cell Longev       Date:  2020-06-17       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.